These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2887923)

  • 1. Detoxification of pertussis vaccines.
    Ashworth LA; Robinson A
    Lancet; 1987 Sep; 2(8559):632. PubMed ID: 2887923
    [No Abstract]   [Full Text] [Related]  

  • 2. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan.
    Pichichero ME; Decker MD
    Biologicals; 2005 Mar; 33(1):59. PubMed ID: 15713557
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 4. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single radial immunodiffusion as a method for the assay of the acellular pertussis vaccine components, pertussis toxoid, filamentous haemagglutinin and pertactin.
    Xing DK; Canthaboo C; Corbel MJ; Schild GC
    Biologicals; 1998 Sep; 26(3):217-24. PubMed ID: 10208723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
    Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the new acellular recombinant pertussis vaccine.
    Rappuoli R; Pizza M; Podda A; De Magistris MT; Ceccarini C; Nencioni L
    Arch Inst Pasteur Tunis; 1994; 71(3-4):557-63. PubMed ID: 8801858
    [No Abstract]   [Full Text] [Related]  

  • 8. Estimation of the bacterial content of pertussis vaccines by dry weight and nitrogen determinations of bacterial mass.
    Csizér Z; Niedermayer N; Szammet A; Zsidai J
    J Biol Stand; 1982 Oct; 10(4):269-72. PubMed ID: 6296154
    [No Abstract]   [Full Text] [Related]  

  • 9. Safer acellular and whole-cell pertussis vaccines.
    Cameron J
    Lancet; 1987 Jun; 1(8547):1427-8. PubMed ID: 2884511
    [No Abstract]   [Full Text] [Related]  

  • 10. Pertussis vaccine.
    Robinson A; Ashworth LA; Irons L
    Lancet; 1982 Jul; 2(8289):108. PubMed ID: 6123801
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of pertactin in pertussis vaccines: the jury is still out.
    Desauziers E; Danve B; Decker MD; Veitch K
    J Infect Dis; 2004 Apr; 189(7):1332-3; author reply 1333-5. PubMed ID: 15031804
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
    Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of acellular pertussis vaccine by assay of serum neutralizing antibodies to pertussis toxin (antitoxin): analogy with diphtheria toxoid.
    Robbins JB; Schneerson R; Trollfors B; Taranger J; Lagergård T
    Dev Biol Stand; 1998; 95():155-8. PubMed ID: 9855426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
    Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA
    Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key points for the development of mouse immunogenicity test as potency assay for acellular pertussis vaccines.
    André M; Poirier B; Bornstein N; Marmonier D; El Zaouk A; Fuchs F
    Biologicals; 2000 Dec; 28(4):217-25. PubMed ID: 11237357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Properties of an acellular preparation of Bordetella pertussis and its analysis after centrifugation in saccharose gradient].
    Letowska I; Kaczurba E; Schiller B
    Med Dosw Mikrobiol; 1993; 45(3):289-94. PubMed ID: 8189799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evaluation of the pertussis component vaccine produced by apoceruloplasmin affinity chromatography.
    Ginnaga A; Morokuma K; Furukawa S; Shigaki T; Katsuki N; Aihara K; Oka T; Sakoh M; Tamura C; Imaizumi A
    Dev Biol Stand; 1991; 73():233-41. PubMed ID: 1778315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third International Standard for pertussis vaccine: international confirmation study of activity of British Standard for pertussis vaccine, coded 66/303.
    Xing DK; Gaines Das R; Newland P; Corbel M
    Biologicals; 2001 Jun; 29(2):133-6. PubMed ID: 11580217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines.
    Tiru M; Jäätmaa E; Gillenius P; Askelöf P
    Dev Biol Stand; 1985; 61():469-75. PubMed ID: 2872128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.